Evotec SE

Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth

23 April 2024

20:40 Corporate

Evotec SE

Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

20:38 Ad-hoc

Evotec SE

Ad-hoc

Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

18 April 2024

13:27 Corporate

Evotec SE

Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments

17 April 2024

15:00 Corporate

Evotec SE

Evotec SE to announce results for fiscal year 2023 on 24 April 2024

Evotec SE

13:07 Advance Financial Reports

Evotec welcomes Aurélie Dalbiez as Chief People Officer

15 April 2024

Evotec SE

Advance Financial Reports

13:03 Advance Financial Reports

Evotec SE

Advance Financial Reports

5 April 2024

16:46 Voting Rights Announcements

Evotec SE

16:13 Voting Rights Announcements

20 March 2024

Evotec SE

6 March 2024

Evotec SE

17:30 Directors’ Dealings

Evotec and Claris Ventures streamline access to accelerate programmes from Claris’s portfolio companies into the clinic

12 February 2024

Evotec SE

Evotec SE: Dr. Cord Dohrmann, sell

7 February 2024

Evotec SE

16:03 Voting Rights Announcements

Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV

5 February 2024

Evotec SE

15:48 Voting Rights Announcements

Evotec SE

13:00 Total Voting Rights

31 January 2024

Evotec SE

Total Voting Rights

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

22 January 2024

14:17 Directors’ Dealings

Evotec SE

Evotec SE: Dr. Werner Lanthaler, sell

Evotec SE

19:07 Directors’ Dealings

Evotec SE: Invitation to Conference Call

18 January 2024

Evotec SE

19:06 Directors’ Dealings

Evotec SE: Dr. Werner Lanthaler, Purchase of shares by exercising stock options (Share Performance Plan)

Evotec SE

19:04 Directors’ Dealings

Evotec SE: Dr. Werner Lanthaler, Purchase of shares by exercising stock options (Share Performance Plan)

Evotec SE

19:03 Directors’ Dealings

Evotec SE: Dr. Werner Lanthaler, Purchase of shares by exercising stock options (Share Performance Plan)

Evotec SE

19:01 Directors’ Dealings

Evotec SE: Dr. Craig Johnstone, Purchase of shares by exercising stock options (Share Performance Plan)

Evotec SE

18:59 Directors’ Dealings

Evotec SE: Dr. Craig Johnstone, Purchase of shares by exercising stock options (Share Performance Plan)

Evotec SE

18:58 Directors’ Dealings

Evotec SE: Dr. Craig Johnstone, Purchase of shares by exercising stock options (Share Performance Plan)

Evotec SE

18:54 Directors’ Dealings

Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan)

Evotec SE

18:52 Directors’ Dealings

Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan)

Evotec SE

18:50 Directors’ Dealings

Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan)

Evotec SE

18:48 Directors’ Dealings

Evotec SE: Dr. Werner Lanthaler, Exercise against Cash Settlement (Share Performance Plan)

Evotec SE

18:44 Directors’ Dealings

Evotec SE: Dr. Werner Lanthaler, Exercise against Cash Settlement (Share Performance Plan)

Evotec SE

Evotec SE: Dr. Werner Lanthaler, Exercise against Cash Settlement (Share Performance Plan)

Upcoming Events

Event Functions

Add to favorite list Remove from favorites

Additional Functions

May 24

Evotec SE

Analysts’ Conference

Boston

May 24

Evotec SE

Press Release – quarterly financial report (call-date Q1)

Jun 24

Evotec SE

Annual General Meeting

Aug 24

Evotec SE

Publication half-yearly financial report

Nov 24

Evotec SE

Publication quarterly financial report (call-date Q3)